Literature DB >> 17075108

Whose opinion counts?

Charles L Loprinzi, Debra L Barton, Jeff A Sloan.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17075108     DOI: 10.1200/JCO.2005.04.4388

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.

Authors:  Charles L Loprinzi; Rui Qin; Ernie P Balcueva; Ernie P Baclueva; Kathleen A Flynn; Kendrith M Rowland; David L Graham; Nancy K Erwin; Shaker R Dakhil; Donald J Jurgens; Kelli N Burger
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

2.  Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.

Authors:  Ian D Schnadig; Erik K Fromme; Charles L Loprinzi; Jeff A Sloan; Motomi Mori; Hong Li; Tomasz M Beer
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

3.  Levetiracetam for the treatment of hot flashes: a phase II study.

Authors:  Susan Thompson; Aditya Bardia; Angelina Tan; Debra L Barton; Lisa Kottschade; Jeff A Sloan; Brad Christensen; DeAnne Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2007-06-28       Impact factor: 3.603

4.  Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network.

Authors:  Janet S Carpenter; Katherine M Newton; Barbara Sternfeld; Hadine Joffe; Susan D Reed; Kristine E Ensrud; Jennifer L Milata
Journal:  Menopause       Date:  2012-06       Impact factor: 3.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.